Search Protocols under revision. Back New search Go to resultsDiseaseMain groupSolid TumorsProtocol groupGastroenterologic OncologyGynecological OncologyThoracic TumorsTumor, regardless of entityDiseaseBile Duct CarcinomaBreast CancerLung Carcinoma, Non-Small CellLung Carcinoma, Small CellPancreatic CancerTumor, Various OrgansTumor Biomarker DefinedSubgroupNRG1-FusionICD10C24.-C24.0C24.1C24.8C24.9C25.-C34.-C50.-MeSHBile Duct NeoplasmsBiliary TractBiliary Tract NeoplasmsBreast NeoplasmsCarcinoma, Non-Small-Cell LungCommon Bile Duct NeoplasmsNeoplasmsPancreatic NeoplasmsSmall Cell Lung CarcinomaSequenceAntineoplastic therapySubstanceCisplatinHydrocortisoneThiotepaZenocutuzumab SubstanceCisplatinHydrocortisoneThiotepaZenocutuzumab SubstanceCisplatinHydrocortisoneThiotepaZenocutuzumab SubstanceCisplatinHydrocortisoneThiotepaZenocutuzumab Anzahl Substanzen12 RadiotherapySupportive therapySubstanceBalanced Crystalloid SolutionDexamethasoneDimetindenParacetamolSubstanceBalanced Crystalloid SolutionDexamethasoneDimetindenParacetamolSubstanceBalanced Crystalloid SolutionDexamethasoneDimetindenParacetamolSubstanceBalanced Crystalloid SolutionDexamethasoneDimetindenParacetamolAnzahl Substanzen4Protocol classificationTherapy classificationalternativeIntensityStandard doseTherapy indicationSecond lineseveral possibleTherapy phaseTherapy intentionpalliativeRisksAnemia Hb below 8g/dlCardiotoxicityDiarrheaEmetogenicityIncrease AminotransferasesInfusion ReactionNauseaVomiting only studiesPublicationAuthorMaisch BMartinoni A Schram AMDiseaseMaligner Perikarderguss, hämodynamisch relevantTumore unterschiedlicher Lokalisation, lokal fortgeschritten oder metastasiert, NRG1-Fusion, Zweitlinie, ECOG 0-2OriginCardiology Unit, Milan, ItalyDepartment of Internal Medicine-Cardiology, Philipps University, Marburg, GermanyMemorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA, eNRGy trialProtocols in Revision 3 protocols foundCisplatin 30, Tumor, Various Organs (PID2371 V1.0)Thiotepa 15 / Hydrocortisone 30, Tumor, Various Organs (PID2372 V1.0)Zenocutuzumab 750, Tumor Biomarker Defined (PID3015 V1.0)
